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Abstract 
Small non coding RNA molecules are widespread in all kingdoms of life, 
where they serve to regulate and fine tune gene expression.  They can act in cis or 
trans, depending upon their structural relationship with genes whose expression they 
influence, and function by interacting with target messenger RNA molecules to inhibit 
or accelerate translation.  Thus, they can exert rapid control on cellular protein levels.  
Within bacteria, many sRNAs have been described in Gram negative model 
organisms but developments in our understanding of their role in Gram positive 
organisms has been slower.  It is clear that sRNAs influence a wide range of cellular 
processes, including adaptation to environmental stresses, and virulence processes 
in pathogens.   
Historically, identification of sRNAs has been challenging but recent 
developments in sequencing technology and computational analysis have led to over 
45000 predicted sRNAs being catalogued in the last few years.  However many of 
these in silico predictions are yet to be validated and the complexity, in terms of 
sRNA interactions with gene networks, means we are really only beginning to 
understand how wide-ranging their effects can be within bacteria.  It is clear that 
sRNAs play a critical role in all aspects of bacterial physiology.  Within the genus 
Clostridium, the role of sRNAs in the pathogens C. perfringens, C. botulinum and C. 
difficile is much less well understood, despite hundreds of sRNAs having been 
predicted within these organisms.  These predictions represent a platform for novel 
discoveries regarding post transcriptional regulatory strategies mediated by these 
molecules in Clostridia.   
Keywords: Regulatory RNA, Post transcriptional regulation, Stress, Virulence, 
Riboswitch, Clostridium, difficile
Introduction. 
The genus Clostridium encompases a heterogeneous group of Gram-positive 
endospore forming obligately anaerobic microorganisms that are ubiquitous in soils 
and the intestines of higher organisms.  Certain species are economically useful and 
relatively benign – for example, C. acetobutylicum, C. beijerinckii and C. 
cellulovorans are employed in the industrial production of biofuels1. However the 
genus is also infamous for the toxin-producing pathogens C. difficile, C. perfringens 
and C. botulinum, whose yearly socioeconomic impact is considerable2,3.  C. difficile 
infection (CDI) causes infectious diarrhoea with associated abdominal pain, cramping 
and low grade fever up to 40.6°C4.  C. difficile pathogenesis and many of the factors 
underlying CDI are well understood, but CDI can still be life-threatening if not treated 
promptly2,4,5.   
The availability of well over 30 C. difficile genome sequences6-9 has afforded 
researchers excellent opportunities to better understand the evolution and lineages of 
these organisms.  Generation of comparative functional genomics datasets has 
lagged somewhat and as a consequence, comparatively little is known about the 
adaptive ability of C. difficile.  Thus in our laboratory we have taken a systems 
approach to understanding the response of C. difficile to clinically relevant heat 
stress, using comparative  proteomics and transcriptomics10,11.  While a classical 
heat shock response and class I chaperone induction was observed at 41°C, we also 
observed downregulation of the flagellum, FliC (CD0239) and several other 
recognised virulence factors, such as cwp20 (CD1469), cwp5 (CD2786) and TcdA 
(CD0663), strengthening the hypothesis that virulence of C. difficile is ‘set’ at 37°C.  
We also determined that the correlation between changes in protein abundances and 
their cognate transcripts was inconsistent.  Several factors could explain this 
observation including protein/mRNA stability, transcription efficiency or unrecognised 
post-transcriptional regulatory mechanisms12.  Recently Chen et al.13 demonstrated 
the presence of small, non coding, regulatory RNA molecules (small RNAs, sRNAs) 
in C. acetobutylicum and proposed a role for them in gene regulation in this 
microorganism.  This review seeks to provide an overview of the key elements of 
sRNA biology and to summarise what is known of their role in Clostridia. 
 
What are Small RNAs? 
Eukaryotic sRNAs 
Small non coding RNAs, including microRNAs (miRNAs) and small interfering 
RNAs (siRNAs) have been identified as regulators of a variety of cellular processes 
in plants and animals14.  First described in Caenorhabditis elegans15 several hundred 
miRNAs, generally ~21-22 nucleotides in length, have now been described.  They 
are generated by cleavage of longer, precursor RNA transcripts that have formed a 
self complementary foldback loop by the RNAseIII-like enzyme Dicer, and function by 
base pairing with target mRNA, initiating its degradation.  Small interfering RNAs 
(siRNAs, <30 nucleotides) are generated by Dicer mediated cleavage of double 
stranded RNA and play a role in RNA interference (RNAi) via the RNA-induced 
silencing complex (RISC), where they guide sequence-specific cleavage of RNAs.  
Thus these small RNAs are functionally interchangeable.  miRNAs have also been 
predicted and experimentally verified in DNA viruses, with the herpesviridae 
containing the largest number of viral miRNAs: for such viruses that undergo 
persistent infection, the invisibility of miRNAs to the adaptive immune response is a 
useful trait16,17.  Indeed, the fact that double stranded (ds) RNAs are quite stable in 
vivo and non immunogenic means that RNAi has great potential for therapeutic 
use18,19.  It is known that miRNAs encoded by both host and infecting viruses enable 
these protagonists to do battle with each other during infection20 and as a result, 
miRNA profiles are becoming recognised as novel means of diagnosis21. 
 
Prokaryotic sRNAs 
Small RNAs were initially identified in bacteria with the identification of 6s RNA 
in E. coli22 but it is only relatively recently that their influence on bacterial cellular 
processes and their varied modes of action have become recognised23.  In contrast 
to shorter eukaryotic or viral miRNAs, bacterial sRNAs (i.e. not tRNA, rRNA or 5S 
RNA) are typically between 50 and 500 nucleotides in length and as with many 
developments in microbial sciences E. coli was, and is, the model organism for study 
of sRNAs.  Knowledge of sRNA biology in Gram positive organisms and in archaea 
has developed more slowly, due in part to a lack of efficient genetic tools24,25.  Initial 
elucidation of an individual sRNA’s function in E. coli came in 1984.  Mizuno and 
colleagues26 showed that an mRNA-interfering complementary RNA (micRNA) that 
was complementary to the 5' end region of the ompF gene mRNA, served to inhibit 
production of the ompF protein by interfering with translation.  This new field of RNA 
biology, dubbed RNOmics27 has since developed and expanded exponentially 
assisted in no small part by technical advances in DNA sequencing technologies and 
the development of computational algorithms for identification of sRNA sequences in 
genomic information (Figure 1). 
 
Functionality of bacterial sRNAs. 
Bacterial sRNAs regulate and fine tune gene expression in bacteria and it is 
thought that they enable a faster response to changing conditions at relatively low 
metabolic cost.  Functional RNA molecules require only limited transcription energy 
compared to other cellular regulatory mechanisms and in addition, less time is 
required for a sRNA to be produced and to impact upon target protein levels28.  A 
wide range of environmental stimuli impact upon sRNA expression and it is not 
surprising that many sRNAs are associated with bacterial stress responses29.  
sRNAs can exert global effects on gene expression.  In the oxidative stress response 
in E. coli, for example, the 109 nucleotide OxyS sRNA is transcribed divergently 
from, and regulated by, the oxyR gene encoding the redox-sensitive transcriptional 
regulator which is the actual sensor of the oxidative shock.  Upon expression of oxyS 
sRNA, translation of rpoS is inhibited with rapid and global effects upon cellular 
physiology29,30.  In E. coli, FlhDC – the master regulator of flagellar biosynthesis – is 
regulated by multiple protein transcription factors that respond to different 
environmental stimuli including cell envelope stress and salt concentration.  However 
the recent work of De Lay and Gottesmann31 has shown that complexity, and thus 
regulatory power, is increased because the 5' untranslated region (5’ UTR) of the 
flhDC mRNA is also subject to negative regulation by six different sRNA molecules 
(ArcZ, OmrA, OmrB, OxyS, SdsR and GadY) and positive regulation by one (McaS).  
Thus, the flhDC mRNA serves as a hub that allows integration of signals derived 
from environmental salt and oxygen concentrations, oxidative insult and the general 
stress response, into the decision to make flagella.  The question of whether the 
flagellum is a primary C. difficile virulence factor is open to debate11, but a flagellar 
filament requires some 2% of a bacterial cell’s total energy consumption under 
optimal growth conditions, in order to synthesise the necessary ~20,000 subunits of 
FliC protein: it is clear why such precise regulation of flagellar biosynthesis might be 
necessary.  It has been suggested that up to ~300 sRNAs will be present in the 
average bacterial genome, a number equivalent to the complement of transcription 
factors32.  As exemplified above, however, these sRNAs have many times the 
potential regulatory capacity of protein transcription factors and thus they are clearly 
of critical importance in bacterial physiology.   
 
How do sRNA molecules exert their biological effect? 
In the Gram-positive bacterial pathogens in which sRNAs have been 
characterised to date, their biological functions have been linked to adaptation or 
virulence.  For example, in C. perfringens, the VR-RNA sRNA regulates collagenase 
and alpha toxin gene transcription33.  Like Gram-negatives, Gram positive bacteria 
have many sRNA-mediated regulatory mechanisms that allow response to 
environmental and intercellular signals via a number of different mechanisms24.  
Bacterial sRNAs are generally found in the intergenic regions of the genome and 
they fall into two main categories depending upon their genomic context in 
relationship to the target gene.  Those that are transcribed independently from the 
target gene are encoded in trans, while those that are co-transcribed, usually from 
within the 5’ UTR of the target transcript, are encoded in cis29 (Figure 2).  Cis 
encoded sRNAs can also be transcribed from the antisense strand at the same 
genetic locus as the target and these antisense RNAs (aRNAs) will therefore exhibit 
perfect complementarity with their target, allowing interactions that impact positively 
or negatively upon gene expression32,34. Cis and trans sRNAs can be further 
categorized into two subgroups based upon their mode of action.  Certain sRNAs 
pair with mRNA targets to affect their stability or translation while others act as 
molecular decoys that bind to protein targets and affect their activity35-39 (Figure 3).  
RNA thermosensors (Figure 4a) have been demonstrated to play pivotal regulatory 
roles in not only the heat stress response, but also in the coordination of expression 
of virulence genes in number of human pathogens40,41 while Riboswitches, a further 
class of cis acting RNA element, control expression of downstream genes via 
metabolite-induced alteration of sRNA secondary structures (Figure 4b).  
Riboswitches can function in a variety of ways but in brief, different metabolites can 
allow them either to induce or repress transcription or translation, as recently 
reviewed by Serganov and Nudler42.  The bacterial sRNAs that have been 
characterised in Gram positive microorganisms are expressed mainly in a growth 
phase-dependent manner and while it may be hypothesised that, like in E. coli, they 
are part of complex regulatory processes our current knowledge of factors affecting 
sRNA expression in Gram positive bacteria is lacking24.  Thus, while sRNAs have 
been characterised in Bacillus subtilus, Listeria monocytogenes, Staphylococcus 
aureus, Streptococcus pyogenes, Clostridium acetylobutylicum and Clostridium 
perfringens, very little is known about their role in C. difficile.   
 
The role of the Hfq RNA chaperone protein.  
While sRNA modes of action are fairly similar between Gram positive and 
Gram negative bacteria, one aspect of sRNA biology that is less well conserved is 
the role of the Hfq RNA chaperone.  Hfq is highly conserved in prokaryotes and 
belongs to the Sm family of proteins that are known to interact with RNA in both 
eukaryotes and prokaryotes43.  Hfq has been shown to interact with a considerable 
number of trans encoded sRNA molecules in Gram negative microbes, where it plays 
a key role in stabilising sRNA molecules or facilitating interaction with mRNA 
targets24,44.  Thus, Hfq plays a key role in one of the most complex post 
transcriptional networks known45.  In low GC Gram-positive bacteria, however, the 
function of Hfq is still unclear43 although in L. monocytogenes, Hfq is required for 
function of several sRNAs (LhrA–C)46.  However, other L. monocytogenes sRNAs do 
not require Hfq for target interaction47 and in S. aureus, Hfq does not seem to be 
required for sRNA-mRNA interactions at all48.  There is also the consideration that 
not all bacterial genomes contain an Hfq homologue, raising the possibility that other 
proteins may be able to substitute for Hfq in certain organisms49.   
 
Identification and validation of sRNAs in bacteria. 
Initial identification of sRNAs in bacteria is challenging, not least because until 
recently there was no general approach that provided a comprehensive solution to 
their prediction21.  Furthermore, sRNA target prediction is awkward because many 
sRNA:mRNA hybridisations occur over relatively short regions of imperfect 
complimentarity50.  The initial work on sRNAs some 40 years ago used gel 
electrophoresis to fractionate radiolabelled total bacterial RNA, followed by elution of 
low molecular mass RNA molecules from the gels and subsequent analysis51.  In the 
30 years since their first discovery, only around a dozen sRNAs were identified and 
characterised in E. coli but since then, developments in genomics and computational 
biology have allowed the field of sRNA biology to expand massively.  In the past 
decade or so, sRNA gene finders based upon well-characterised sequences and 
algorithms to predict the minimum free energy of structured RNAs have been applied 
to newly catalogued bacterial genomes52,53.  In addition, comparative genomics 
approaches that allow researchers to make sRNA predictions based upon the 
presence of rho independent terminators and promoters and other features in the 
intergenic regions have also been used to predict sRNAs13,50,54.   
A workflow for sRNA characterisation, therefore, might proceed from in silico 
identification of sRNAs to demonstration of their expression by qRT-PCR or Northern 
Blotting and the subsequent identification of direct and indirect targets of individual 
sRNA molecules using in silico prediction algorithms followed by wet lab methods to 
validate the interactions.  For example, in the work of Chen et al.,13 the only report to 
date on genome wide characterisation of sRNAs in clostridia, in silico methods were 
used to predict sRNAs in 21 clostridial species.  The authors then used qRT-PCR to 
validate 30 sRNAs of 113 predicted in C. acetobutylicum, and 21 from C. botulinum, 
thus showing that qRT-PCR is a useful first screening step.  Highly expressed sRNAs 
(by qRT-PCR) were then analysed using Northern blotting to validate transcript sizes 
against those predicted by the in silico analysis.  A number of additional experimental 
approaches can also be used including tiling oligonucleotide microarrays, cDNA 
cloning and high throughput RNAseq54-56.  In addition, the identification of sRNA:Hfq 
associations can provide further evidence that transcripts are sRNAs45.   
 
Databases for sRNA research. 
Concomitantly with these predictive methods and experimental validations, the 
development of user friendly, browser based databases and software tools to allow 
information retrieval and analysis has proceeded apace.  As with other post-genomic 
fields, for example mass spectrometry-driven proteomics,57 these developments have 
been crucial to the expansion of sRNA biology as a field of research.  Within even the 
last few years, the number of sRNAs identified in a wide range of bacteria, including 
in Gram positives, has increased at an incredible rate.  A natural consequence of this 
success is an increasing urgency for identification of their cellular targets and 
functional roles, a facet of the research which has lagged considerably behind 
identification studies58.  A number of groups have presented a variety of tools for the 
purposes of sRNA identification59.  One of the longest standing is the Rfam database 
(http://rfam.sanger.ac.uk), a collection of non-coding RNA families represented by 
multiple sequence alignments and secondary structure predictions that was first 
developed a decade ago60,61.  The work of Livny et al. introduced the powerful SIPHT 
tool (sRNA identification protocol using high-throughput technologies), which 
incorporates a number of programs and adjustable search parameters to identify 
sRNAs and other features in an automated fashion50.  SIPHT identifies conserved 
sequences along with rho independent terminators and promoters in intergenic 
regions and incorporates BLAST, genomic synteny and transcription factor binding 
site analyses into a workflow that yields an output that can be opened in Excel.  This 
work has allowed prediction of candidate sRNA encoding loci from over 900 bacterial 
genomes and plasmids within the NCBI database, thus expanding the number of 
predictions from several hundred candidate sRNAs to over 45,000.  However all 
databases will have perceived drawbacks, regardless of how they are implemented.  
They might not allow further analysis, or they may be restricted to a limited number of 
bacterial species, or be reliant upon published data.  Two recent publications have 
sought to redress this deficiency: sRNAdb, developed by Pischimarov and 
colleagues50 is a user-friendly searchable database allowing comprehensive 
comparative analysis of sRNAs from Gram positive microorganisms.  In addition, 
further features of interest may be incorporated by the end user into a local 
customised database.  The work of Li et al. describes BSRD – a repository for 
bacterial small regulatory RNA62 which is said to contain more experimentally 
validated sRNAs than any other database and enables researchers to identify and 
characterise sRNAs in large scale transcriptome sequencing projects.  Thus, 
researchers interested in a particular bacterial group now have at their disposal a 
comprehensive range of predictions, databases and in silico analysis tools to 
underpin their investigations.   
 
Identification of sRNA targets – dissection of roles and functions. 
Having validated the existence of a population of sRNAs, there remains the 
issue of what individual sRNA molecules actually do.  It is clear that only a relatively 
small proportion of the sRNAs predicted to date have had their targets experimentally 
verified, although targets can initially be inferred computationally.  Many sRNAs are 
antisense regulators and bioinformatics searches for complementarity can assist with 
target identification – although in reality, the base pairing between sRNAs and their 
targets is often imperfect, making this task difficult58.  One such tool, sTarPicker, is 
based upon a mathematical model of hybridisation between sRNA and mRNA and is 
said to predict sRNA targets with higher efficiency than competing programmes63.  
sRNATarBase, developed by the same group, seeks to provide a resource of sRNA 
targets that have been experimentally verified, thus providing support for predictive 
models and subsequent in silico and functional analyses.  The authors systematically 
and manually collected sRNA:target interaction data from published papers in order 
to develop their database of sRNA targets64.  However, where targets are as yet only 
inferred, is still necessary to validate these sRNA:target predictions and to this end, 
several interesting approaches can be used.  In addition, the determination of what 
constitutes a primary target (direct interaction with the sRNA) and what is a 
secondary target, such as a transcription factor, is also of considerable importance58.   
Analysis of the sRNA and proposed target mRNA expression under different 
conditions is one approach to target identification.  As reported by Chen et al., a 
conserved novel sRNA (CAC610) in C. acetobutylicum and a downstream gene 
(CAC0528) both responded to the antibiotic clindamycin.  As the distance between 
the sRNA and the gene was conserved across a number of clostridial strains at 
~185bp (although neither exist within in C. difficile), the authors concluded that there 
was a functional relationship between the two, although the exact mechanism by 
which the sRNA might modulate gene expression (or vice versa) was not 
determined13.  Another method for determination of sRNA targets has been 
described as a ‘biochemical fishing expedition’.  The use of sRNA molecules as the 
bait in order to capture a mRNA target is an approach that can be further refined by 
incorporating a recombinant affinity tagged Hfq protein.  As many sRNAs interact 
with Hfq, its subsequent purification, complete with sRNA and the sRNA target, can 
allow sRNA target identification.  In this instance, creation of cDNA clones, and their 
hybridisation to whole genome microarrays could be employed65.  Functional 
genomics analyses, for instance with mutants constructed in validated sRNA 
encoding regions of the genome, allows the subsequent determination of the effect of 
these deletions on both host cell physiology and on the expression of predicted 
targets66,67.  With mutants in hand, tiling oligonucleotide microarrays, or RNAseq 
analysis, would provide a genome-wide picture of their effect.  Furthermore, it should 
be possible to experimentally express a high level of a given sRNA in a host cell, and 
compare global cellular responses with those of either the wild type or a deletion 
mutant.   
 
Conclusions and future perspectives 
RNOmics is still a rapidly expanding field and it is clear that advances in our 
understanding will be driven by the use of high throughput post genomic technologies 
such as transcriptome sequencing.  Focus will also be required to determine the 
functions of individual bacterial sRNAs which is a not inconsiderable task given the 
potential for widespread interactions of sRNAs with multiple targets and within gene 
networks.  There is still much to be done to experimentally validate sRNA predictions 
in clostridia, where it appears that the number of sRNAs is related to the physiology 
of the organism.  Greater numbers of sRNAs have been predicted in the genomes of 
pathogenic clostridia – for example C. difficile 630 is predicted to contain 264 sRNAs, 
none of which have been experimentally verified as yet13.  Clostridial sRNAs appear 
to be phylogenetically restricted to these organisms and are not conserved in, for 
example, Bacilli, thus it will be of interest to determine precisely under what 
conditions these sRNAs are expressed, and whether strain to strain variations exist – 
between different C. difficile ribotypes, for example.   
The work so far on C. acetobutylicum suggests that certain sRNAs may play a 
role in antibiotic resistance and this observation provides new avenues for research 
into antibiotic tolerance mechanisms, drug targets and diagnostic methods.  At 
present, there is no data on the role of the Hfq homologues that exist in the genomes 
of Clostridium spp, although with functional genomics tools such as ClosTron68 it 
should be possible to construct gene knockouts and determine the role of Hfq.  Our 
understanding of small RNAs in Clostridia is at present incomplete, presenting the 
research community with an opportunity to define the roles of these molecules within 
these anaerobic microorganisms.  
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Figure 1: The rise in RNomics over the last decade.   
Year on year (a) and Cumulative total (b) publications from the Web of Knowledge 
database that contain both “sRNA*” and “bacteria*” in the title.  It is clear that we are 
in exponential phase of this new and exciting research area and also that there is a 
significant body of literature. 
 
Figure 2:  Generalised genomic context of cis and trans acting small RNAs. 
Cis acting sRNAs are generally found in the 5’ untranslated region of the mRNA 
(5’UTR), although less commonly, they may be encoded in the 3’UTR.  Riboswitches 
and RNA thermometers fall into this class of sRNAs. 
Trans acting sRNAs are encoded in intergenic regions of the genome (characterised 
by the presence of rho independent terminators and promoters in their sequence) 
and are transcribed independently of the target.  They usually act by base pairing 
(often assisted by the Hfq RNA chaperone protein) with the target mRNA, influencing 
the output from that mRNA. 
 
Figure 3:  Small RNA molecules can act to modulate gene expression in a variety of 
ways.   
Base pairing of the sRNA with a target mRNA sequence can lead to (a) termination 
of transcription, (b) degradation of the mRNA, (c) occlusion of the ribosome binding 
site (RBS) and decreased translation or (d) changes in the secondary structure of 
mRNA such that the RBS is more accessible by the 30S ribosome and translation is 
increased.  In an alternative mechanism, the (trans encoded) sRNA acts as a 
molecular decoy – here, binding of an inhibitor protein to the mRNA prevents 
translation but if the inhibitor is sequestered by binding to the decoy sRNA, 
repression is lifted. 
 
Figure 4.  RNA thermometers and Riboswitches are examples of cis encoded small 
RNA molecules.  
(A)  At low temperature, the 30S ribosome is prevented from accessing the shine 
dalgarno (SD) sequence and the start codon (AUG) due to the complex secondary 
structure of the mRNA.  Upon increasing temperature the secondary structure 
gradually melts and the ribosome can access the SD and AUG.  This is thus a faster, 
direct, temperature sensing mechanism which is known to regulate heat shock gene 
expression and virulence in bacteria.  Sequence conservation in the 5’ aptamer 
domain enables database searches for identification of these thermosensing 
elements.  
(B)  Generalised mechanism for expressional control via metabolite binding to cis 
acting riboswitches.  The riboswitch consists of a sensor aptamer domain which can 
bind the metabolite (for example, anions, metal ions, co factors, purines and amino 
acids are all known to direct switching) and an expression platform.  Riboswitches 
sense different concentrations of a single metabolite and upon highly discriminatory 
binding of the metabolite to the aptamer domain, the secondary structure of the 
element changes to allow changes in transcription, translation, splicing and mRNA 
stability.   
 
 
 




